Shilpa Medicare

Shilpa Medicare subsidiary receives CEP from EDQM for Teriflunomide API

Shilpa Medicare secures Portugal marketing authorization for Tadalafil Orodispersible Films

Shilpa Medicare receives GMP certification for units IV and VII in Telangana

Shilpa Pharma Lifesciences Limited receives CEP from EDQM for Octreotide API

This marks the second peptide molecule in Shilpa's expanding peptide portfolio.

Shilpa Medicare shares surge 4% on strong Q2 FY25 financial performance

Stock to Watch: Shilpa Medicare reports robust Q2 FY25 performance with 11% revenue growth and 1008% PAT increase

Shilpa Medicare announces USFDA acceptance of NDA for Oxylanthanum Carbonate filed by Unicycive

Shilpa Medicare shares jump 3% as CDMO customer secures USFDA Fast Track Designation for GBM Drug

Shilpa Medicare shares surge over 2% after arm gets CEP from EDQM for Desmopressin

Shilpa Pharma Lifesciences receives CEP for Desmopressin from EDQM

Shilpa Medicare shares rise 4% to after Antique initiates ‘Buy’ rating with target price of ₹1300

Shilpa Medicare Stock: Share price surges 9% this week on USFDA approval for Bortezomib Injection

Shilpa Medicare gets USFDA approval for Bortezomib Injection

Shilpa Medicare reports successful outcome of Phase 3 studies of SMLNUD07 – NorUDCA

Shilpa Medicare shares rise 3% after subsidiary receives GMP certification from Mexico